STARHEALTH Q2 FY27 Results & Earnings Analysis
Sentiment: Good (Confidence: high)
Earnings Summary
Star Health reported strong Q2 FY27 results with GWP up 19% YoY to Rs.5,275 crore, PAT more than tripled YoY to Rs.265 crore, and underwriting profit of Rs.99 crore vs. loss of Rs.40 crore last year. The company has delivered 5 successive quarters of improving loss ratios and underwriting results, driven by risk-based pricing, portfolio optimization, and claims efficiency. Digital and AI initiatives are scaling, with D2C channel growing 137% YoY. Management aspires to sustain 20%+ fresh business growth and improve combined ratio and ROE. Regulatory reforms are being monitored, with Star Health confident in its proprietary distribution model.
Management Tone
- Prepared Remarks: Great — Prepared remarks highlighted structural turnaround, 5 quarters of improving loss ratios, strong premium growth, digital/AI investments, and proactive regulatory positioning. Tone was confident and optimistic.
- Q&A Session: Good — Analysts asked detailed questions on growth sustainability, loss ratio drivers, investment strategy, and regulatory impact. Management provided direct answers with quantification where possible, though some data was deferred offline.
Revenue Growth Drivers
- Fresh retail health GWP growth of 35% YoY
- Increase in new-to-insurance policies by over 10% YoY
- Rise in average sum insured by 13% YoY
Growth vs Margin Focus
Management emphasized growth of 20%+ on fresh business while also focusing on combined ratio and ROE improvement to mid-teens to higher teens. They are investing in digital and distribution to drive both growth and operating leverage.
About Star Health and Allied Insurance Company Limited
Star Health and Allied Insurance Company Limited (STARHEALTH) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.